The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from the randomized phase 3 DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide plus bortezomib and dexamethasone (PVd) in relapsed/refractory multiple myeloma (RRMM).
 
Suzanne Trudel
Honoraria - Amgen; BMS GmbH & Co. KG; GlaxoSmithKline; Janssen Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - BMS GmbH & Co. KG; GlaxoSmithKline; Roche
Research Funding - Amgen (Inst); BMS GmbH & Co. KG (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Roche (Inst)
 
Meral Beksac
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Oncopeptides; Sanofi Pasteur; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen-Cilag; Sanofi Pasteur
Travel, Accommodations, Expenses - Amgen; Janssen; Sanofi; Takeda
 
Luděk Pour
No Relationships to Disclose
 
Sosana Delimpasi
Honoraria - Amgen; GlaxoSmithKline; Janssen
Speakers' Bureau - Amgen; Janssen; Takeda
 
Hang Quach
Consulting or Advisory Role - Celgene; GlaxoSmithKline
Research Funding - Amgen (Inst); BMS GmbH & Co. KG (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst)
Other Relationship - Amgen; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Vladimir I. Vorobyev
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Janssen Oncology; Novartis; Roche; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; BeiGene; BioCad; BMSi; Janssen; MSD; Novartis; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Michele Cavo
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini Group; Sanofi; Takeda
Consulting or Advisory Role - Amgen, AbbVie, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Karyopharm Therapeutics, Menarini Stemline, Sanofi, and Karyopharm Therapeutics
Speakers' Bureau - Celgene/Bristol-Myers Squibb; Janssen
 
Kazuhito Suzuki
Honoraria - BMS GmbH & Co. KG; Janssen; Ono Pharmaceutical; Sanofi; Takeda
 
Pawel Robak
No Relationships to Disclose
 
Kristin Morris
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Amy Phillips-Jones
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Xiaoou Linnette Zhou
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Giulia Fulci
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Neal Sule
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Brandon Kremer
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Joanna Opalinska
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Blenrep related patents
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Kite, a Gilead company; Pfizer; Regeneron; Roche/Genentech; Stemline Therapeutics; Takeda
 
Meletios Athanasios Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda